Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are unde ...

Viatris Inc. (NASDAQ:VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 January 14, 2025 11:15 AM ET Company Participants Scott Smith - CEO Doretta Mistras - CFO Philippe Martin - Chief R&D Officer Corinne Le Goff - Chief Commercial Officer Conference Call Participants Chris Schott - JPMorgan Chris Schott Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be hosting a fireside chat today with Viatris. From the company we're going to have a quick presentation from CEO, Scot ...

Key Points Company Overview 1. **Company Name and Stock Symbol**: Viatris Inc. (NASDAQ: VTRS) 2. **Event**: 43rd Annual J.P. Morgan Healthcare Conference 2025 3. **Date and Time**: January 14, 2025, 11:15 AM ET 4. **Participants**: - Scott Smith - CEO - Doretta Mistras - CFO - Philippe Martin - Chief R&D Officer - Corinne Le Goff - Chief Commercial Officer - Chris Schott - JPMorgan [1] Forward-Looking Statement 1. **No Guidance Provided**: The company will not be commenting on the full year 2024 or providing guidance for 2025 during the presentation. [2] Financial Highlights 1. **Revenue**: $15 billion in the last 12 months 2. **Adjusted EBITDA**: $4.8 billion in the last 12 months 3. **Free Cash Flow**: $2.4 billion in the last 12 months 4. **Financial Strength**: Viatris demonstrates tremendous financial strength [3] Business Segments 1. **Global Generics Business**: Strong global generics business 2. **Iconic Brands**: Home to iconic brands in the pharma world, including Lipitor, Lyrica, Celebrex, Norvasc, Viagra, etc. [3] Geographic Presence 1. **Global Operations**: Operates in 165 countries around the world [4]

43rd Annual J.P. Morgan Healthcare Conference Forward Looking Statements & Non-GAAP Financial Measures Forward Looking Statements This presentation contains "forward-looking statements". These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about our balanced capital allocation framework; expect capital allocation to be more heavily weighted towards capital return i ...

PITTSBURGH, Jan. 7, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025. The company's presentation and fireside chat will begin at 8:15 a.m. PT / 11:15 a.m. ET.A live webcast of the event can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the sam ...

Conservative Income Portfolio - The Conservative Income Portfolio targets the best value stocks with the highest margins of safety and uses the best-priced options to further lower investment volatility [1] - The Enhanced Equity Income Solutions Portfolio within the Conservative Income Portfolio is designed to reduce volatility while generating 7-9% yields [1] - The portfolio offers an 11-month money-back guarantee for first-time members [1] Viatris Inc (VTRS) - Viatris Inc (NASDAQ: VTRS) has been consistently rated as a "hold" since early 2021, with no "buy" or "sell" ratings issued during that period [2] Trapping Value and Preferred Stock Trader - Trapping Value is a team of analysts with over 40 years of combined experience in generating options income while focusing on capital preservation [3] - Trapping Value runs the Conservative Income Portfolio in partnership with Preferred Stock Trader, which features two income-generating portfolios and a bond ladder [3] - The Covered Calls Portfolio focuses on lower volatility income investing with an emphasis on capital preservation [2] - The Fixed Income Portfolio focuses on buying securities with high income potential and heavy undervaluation relative to comparatives [2]

Biomarker data from CARE study characterizing cenerimod's mechanism of action in systemic lupus erythematosus also published in the Annals of the Rheumatic DiseasesPITTSBURGH, Dec. 18, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the publication of Phase 2b CARE study results evaluating the efficacy and safety of cenerimod in adults with moderate-to-severe systemic lupus erythematosus (SLE). The results, published in Lancet Rheumatologyi, showed cenerimod 4 mg demonstrated clinically mea ...

Viatris Inc. (NASDAQ:VTRS) Jefferies London Healthcare Conference Transcript November 21, 2024 5:30 AM ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Corinne Le Goff - Chief Commercial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo All right. Good morning, everybody. Thanks. Why don’t we get started? For those of you who don’t know me, I’m Glen Santangelo. I’m the analyst at Jefferi ...

Viatris Inc. (NASDAQ:VTRS) Jefferies London Healthcare Conference Transcript November 21, 2024 5:30 AM ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Corinne Le Goff - Chief Commercial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo All right. Good morning, everybody. Thanks. Why don’t we get started? For those of you who don’t know me, I’m Glen Santangelo. I’m the analyst at Jefferi ...

Viatris Inc. (NASDAQ:VTRS) UBS Global Healthcare Conference November 12, 2024 11:45 AM ET Company Participants Doretta Mistras - CFO Conference Call Participants Ashwani Verma - UBS Ashwani Verma Good day, everybody. My name is Ash Verma, I cover SMID-cap, biotech and spec pharma at UBS, and welcome to UBS Global Healthcare Conference with us. Our next session is with Viatris. I'm really pleased to introduce you to Doretta Mistras, who is the CFO at Viatris. Doretta Mistras Great. Thanks, Ash, and very plea ...